Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices

被引:70
作者
Moro, MA [1 ]
De Alba, J
Cárdenas, A
De Cristóbal, J
Leza, JC
Lizasoain, I
Díaz-Guerra, MJM
Boscá, L
Lorenzo, P
机构
[1] Univ Complutense Madrid, Fac Med, Dept Farmacol, Madrid 28040, Spain
[2] UCM, Fac Farm, CSIC, Inst Bioquim, Madrid, Spain
关键词
aspirin; brain ischaemia; excitatory amino acids; glutamate; iNOS; neuroprotection; nitric oxide; nuclear factor-kappa B;
D O I
10.1016/S0028-3908(99)00226-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acetylsalicylic acid (ASA, Aspirin) is an anti-inflammatory drug with a wide spectrum of pharmacological activities and multiple sites of action. Apart from its preventive actions against stroke due to its antithrombotic properties, recent data in the literature suggest that high concentrations of ASA also exert direct neuroprotective effects. We have used an in vitro model of brain ischaemia using rat forebrain slices deprived of oxygen and glucose to test ASA neuroprotective properties. We have found that ASA inhibits neuronal damage at concentrations lower than those previously reported (0.1-0.5 mM), and that these effects correlate with the inhibition of excitatory amino acid release, of NF-KB translocation to the nucleus and iNOS expression caused by ASA. All of these three mechanisms may mediate the neuroprotective effects of this drug. Our results also show that the effects of ASA are independent of COX inhibition. Taken together, our present findings show that ASA is neuroprotective in an in vitro model of brain ischaemia at doses close to those recommended for its antithrombotic effects. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1309 / 1318
页数:10
相关论文
共 40 条
[1]   Prostaglandins stimulate calcium-dependent glutamate release in astrocytes [J].
Bezzi, P ;
Carmignoto, G ;
Pasti, L ;
Vesce, S ;
Rossi, D ;
Rizzini, BL ;
Pozzan, T ;
Volterra, A .
NATURE, 1998, 391 (6664) :281-285
[2]   Protective effect of N-(3-(aminomethyl benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation [J].
Cárdenas, A ;
De Alba, J ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 354 (2-3) :161-165
[3]   SEVERITY OF STROKE AND ASPIRIN [J].
CAROLEI, A ;
PRENCIPE, M ;
FIORELLI, M ;
FIESCHI, C .
NEUROLOGY, 1986, 36 (07) :1010-1011
[4]  
CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171
[5]  
CHOI DW, 1987, J NEUROSCI, V7, P357
[6]  
CORTAS NK, 1990, CLIN CHEM, V36, P1440
[7]   Down-regulation of neuronal nitric oxide synthase by nitric oxide after oxygen-glucose deprivation in rat forebrain slices [J].
De Alba, J ;
Cárdenas, A ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Boscá, L ;
Lizasoain, I .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :248-254
[8]   Use of brain slices in the study of pathogenic role of inducible nitric oxide synthase in cerebral ischemia-reperfusion [J].
De Alba, J ;
Cárdenas, A ;
Moro, MA ;
Leza, JC ;
Lorenzo, P ;
Lizasoain, I .
GENERAL PHARMACOLOGY, 1999, 32 (05) :577-581
[9]   Evidence for common mechanisms in the transcriptional control of type II nitric oxide synthase in isolated hepatocytes - Requirement of NF-kappa B activation after stimulation with bacterial cell wall products and phorbol esters [J].
DiazGuerra, MJM ;
Velasco, M ;
MartinSanz, P ;
Bosca, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :30114-30120
[10]   Pathobiology of ischaemic stroke: an integrated view [J].
Dirnagl, U ;
Iadecola, C ;
Moskowitz, MA .
TRENDS IN NEUROSCIENCES, 1999, 22 (09) :391-397